Skip to main content

Table 1 Baseline demographics and clinical characteristics of the study population at the time of VA placement according to patient age

From: Effects of patient age on patency of chronic hemodialysis vascular access

 

< 65 years

n = 445

≥65 years

n = 206

P-value

Age (years)

50.0 ± 10.2

72.7 ± 5.5

<  0.01

Female sex

169 (38.0)

92 (44.7)

0.11

BMI (kg/m2)

23.3 ± 3.6

23.1 ± 3.7

0.46

Type of VA

 AVF

398 (89.4)

123 (59.7)

<  0.01

  Forearm

206 (51.8)

58 (47.2)

0.37

  Upper arm

192 (48.2)

65 (52.8)

 

 AVG

47 (10.6)

83 (40.3)

 

  Forearm

24 (51.1)

25 (30.1)

0.02

  Upper arm

23 (48.9)

58 (69.9)

 

On hemodialysis

232 (52.1)

127 (61.7)

0.02

Underlying diseases

 Hypertension

373 (83.8)

181 (87.9)

0.18

 DM

200 (44.9)

124 (60.2)

<  0.01

 Smoker

105 (23.6)

44 (21.4)

0.53

 CVD

55 (12.4)

71 (34.5)

<  0.01

 CVA

31 (7.0)

43 (20.9)

<  0.01

 PAOD

19 (4.3)

17 (8.3)

0.04

Medications

 Anti-platelets

184 (41.3)

122 (59.2)

<  0.01

 Anti-coagulants

28 (6.3)

11 (5.3)

0.63

Early mortalitya

12 (2.7)

16 (7.8)

<  0.01

Maturation failureb

26 (5.8)

11 (5.3)

0.80

Early thrombosisc

12 (2.7)

10 (4.9)

0.16

  1. Continuous data are expressed as mean ± standard deviation, and categorical data as number (%)
  2. AVF Autologous arteriovenous fistula, AVG Arteriovenous graft, BMI Body mass index, CVA History of cerebrovascular accident, CVD Cardiovascular disease, DM Diabetes mellitus, PAOD Peripheral arterial occlusive disease, VA Vascular access
  3. a All-cause mortality within 3 months of VA placement but before use
  4. b AVF maturation failure
  5. c Absence of thrill and/or flow within 30 days of hemodialysis initiation via a functioning VA